Around the world, Sirtex works with research and community groups who also share our vision.
We support emerging and established researchers dedicated to developing advanced new interventional therapies.
Our focus in this area is on translational research and the practical application of new technologies, innovation and insights.
We sponsor the Sirtex Excellence in Translational Medicine Award which is coordinated by the Cancer Institute of New South Wales and the Premier of New South Wales. Read more..
In 2013 we announced funding for a professorial research chair at the Australian National University in Canberra. Read more...
A world-leading research team led is seeking new ways to use radioactive nano-particles in a range of medical treatments.
Sirtex also funds a large number of small independent research studies aimed at developing knowledge and awareness of new oncology therapies.
We also provide educational grants for continuing medical education.
Our collective goal is to help convert the insights of talented researchers into useful medical therapies that can be used to improve outcomes for patients.
Sirtex is committed to supporting volunteer groups who help patients and their families around the world.
One of our high-profile partnerships is our collaboration with the international group YES.
YES advocates worldwide to increase funding for research and provides support and information for people with liver tumours.
Our goal is to help find new ways to raise awareness, increase outreach and facilitate collaboration in an effort to improve the outcomes for patients and their families.
YES is headed by spokeswoman Suzanne Lindley who was treated with SIR-Spheres Y-90 resin microspheres more than a decade ago.
Suzanne's story is inspiring and we encourage you to read more about it.